HIMS & HERS HEALTH, INC. (HIMS)
Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications
Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications
What Underwear Should You Buy for Fall? Duluth Trading Shares First-Layer Essentials for Back to Campus and Back to Work
VRT Alert: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vertiv Holdings Co (NYSE: VRT) Investors with Significant Losses to Contact Firm
Frontier Nuclear and Minerals Announces 2026 Annual General Meeting Results
MCB Alert: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Metropolitan Bank Holding Corp. (NYSE: MCB) Investors with Significant Losses to Contact Firm
Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
Sodexo réalise une émission obligataire d’un montant de 1 100 000 000 d’euros
Sodexo completes a euro-denominated bond issuance of EUR 1,100,000,000
Pinnacle Bancshares Declares $0.27 Per Share Quarterly Cash Dividend
DEADLINE APPROACHING: Berger Montague Advises Hub Group, Inc. (NASDAQ: HUBG) Investors to Inquire About a Securities Fraud Class Action by August 28, 2026